John W. LaRocca
2020
In 2020, John W. LaRocca earned a total compensation of $945.1K as General Counsel and Assistant Secretary at Aerie Pharmaceuticals, a 63% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $207,300 |
|---|---|
| Option Awards | $212,087 |
| Salary | $442,900 |
| Stock Awards | $74,130 |
| Other | $8,663 |
| Total | $945,080 |
LaRocca received $442.9K in salary, accounting for 47% of the total pay in 2020.
LaRocca also received $207.3K in non-equity incentive plan, $212.1K in option awards, $74.1K in stock awards and $8.7K in other compensation.
Rankings
In 2020, John W. LaRocca's compensation ranked 8,863rd out of 13,090 executives tracked by ExecPay. In other words, LaRocca earned more than 32.3% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 8,863 out of 13,090 | 32nd |
Division Manufacturing | 3,784 out of 5,621 | 33rd |
Major group Chemicals And Allied Products | 1,532 out of 2,254 | 32nd |
Industry group Drugs | 1,335 out of 1,954 | 32nd |
Industry Biological Products, Except Diagnostic Substances | 309 out of 411 | 25th |
Source: SEC filing on April 27, 2021.
LaRocca's colleagues
We found five more compensation records of executives who worked with John W. LaRocca at Aerie Pharmaceuticals in 2020.
2020
Vicente Anido
Aerie Pharmaceuticals
Chief Executive Officer
2020
Thomas Mitro
Aerie Pharmaceuticals
Chief Operating Officer
2020
Richard Rubino
Aerie Pharmaceuticals
Chief Financial Officer
2020
Casey Kopczynski
Aerie Pharmaceuticals
Chief Scientific Officer
2020
David Hollander
Aerie Pharmaceuticals
Chief Research and Development Officer
News
Aerie Pharmaceuticals CEO Vicente Anido's 2021 pay rises 4% to $3.8M
April 26, 2022
Aerie Pharmaceuticals CEO Vicente Anido's 2020 pay falls 35% to $3.6M
April 27, 2021
Aerie Pharmaceuticals CEO Vicente Anido's 2019 pay slips 18% to $5.5M
April 24, 2020
Aerie Pharmaceuticals CEO Vicente Anido's 2018 pay falls 33% to $6.8M
April 10, 2019